Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Industry Insights

Science and business issues impacting the China biotech industry...

Sino Biological Partners AI Antibody Development Prediction Platform for CRO

China Showcase Panel: Life Science Investing in China's Golden Age

2021 China Life Science Investment Climbs 55% Over 2021's Results

3SBio Acquires China Rights to Numab Immunotherapy

Arbor, a US Gene Editing Company, Raises $215 Million Led by Singapore, Hong Kong, US Investors

ChinaBio Event
Beijing and Digital
September 13-16, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022